Computational analysis to repurpose drugs for COVID-19 based on transcriptional response of host cells to SARS-CoV-2

BACKGROUND: The Coronavirus Disease 2019 (COVID-19) pandemic has infected over 10 million people globally with a relatively high mortality rate. There are many therapeutics undergoing clinical trials, but there is no effective vaccine or therapy for treatment thus far. After affected by the Severe A...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Fuhai, Michelson, Andrew P., Foraker, Randi, Zhan, Ming, Payne, Philip R. O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789899/
https://www.ncbi.nlm.nih.gov/pubmed/33413329
http://dx.doi.org/10.1186/s12911-020-01373-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789899/
https://www.ncbi.nlm.nih.gov/pubmed/33413329
http://dx.doi.org/10.1186/s12911-020-01373-x

Ejemplares similares